Skip to main content
main-content

Zeitschrift

Breast Cancer Research and Treatment

Breast Cancer Research and Treatment 2/2020

Ausgabe 2/2020

Inhaltsverzeichnis ( 24 Artikel )

09.04.2020 | Review | Ausgabe 2/2020

Mechanistic basis for PI3K inhibitor antitumor activity and adverse reactions in advanced breast cancer

Pamela R. Drullinsky, Sara A. Hurvitz

10.04.2020 | Review | Ausgabe 2/2020

Complete pathologic response rate to neoadjuvant chemotherapy increases with increasing HER2/CEP17 ratio in HER2 overexpressing breast cancer: analysis of the National Cancer Database (NCDB)

Kathriena Greenwell, Lala Hussain, David Lee, Matthew Bramlage, Gordon Bills, Apurva Mehta, Amie Jackson, Barbara Wexelman

17.04.2020 | Review | Ausgabe 2/2020

Surveillance for second breast cancer events in women with a personal history of breast cancer using breast MRI: a systematic review and meta-analysis

Cameron B. Haas, Larissa Nekhlyudov, Janie M. Lee, Sara H. Javid, Mary Bush, Dianne Johnson, Timothy Gleason, Cary Kaufman, Jennifer Specht, Sean Stitham, Karen J. Wernli

20.04.2020 | Review | Ausgabe 2/2020

Evaluation and management of insomnia in women with breast cancer

Agnes Kwak, Jamie Jacobs, Dana Haggett, Rachel Jimenez, Jeffrey Peppercorn

21.04.2020 | Review | Ausgabe 2/2020

Bone modifying agents for bone loss in patients with aromatase inhibitor as adjuvant treatment for breast cancer; insights from a network meta-analysis

Hirotaka Miyashita, Sera Satoi, Toshiki Kuno, Christina Cruz, Stephen Malamud, Se-Min Kim

21.04.2020 | Review | Ausgabe 2/2020

Carbon ion radiation therapy in breast cancer: a new frontier

Timothy D. Malouff, Anita Mahajan, Robert W. Mutter, Sunil Krishnan, Bradford S. Hoppe, Chris Beltran, Daniel M. Trifiletti, Laura A. Vallow

10.04.2020 | Preclinical study | Ausgabe 2/2020

Suppression of breast cancer metastasis and extension of survival by a new antiestrogen in a preclinical model driven by mutant estrogen receptors

Mary J. Laws, Yvonne Ziegler, Sayyed Hamed Shahoei, Parama Dey, Sung Hoon Kim, Mayuri Yasuda, Ben Ho Park, Kendall W. Nettles, John A. Katzenellenbogen, Erik R. Nelson, Benita S. Katzenellenbogen

13.04.2020 | Preclinical study | Ausgabe 2/2020

Lymphovascular invasion in breast cancer is associated with gene expression signatures of cell proliferation but not lymphangiogenesis or immune response

Mariko Asaoka, Santosh K. Patnaik, Frank Zhang, Takashi Ishikawa, Kazuaki Takabe

20.04.2020 | Preclinical study | Ausgabe 2/2020

BRCA1 promoter methylation in breast cancer patients is associated with response to olaparib/eribulin combination therapy

Asuka Kawachi, Satoshi Yamashita, Eriko Okochi-Takada, Akihiro Hirakawa, Hitoshi Tsuda, Akihiko Shimomura, Yuki Kojima, Kan Yonemori, Yasuhiro Fujiwara, Takayuki Kinoshita, Toshikazu Ushijima, Kenji Tamura

06.04.2020 | Clinical trial | Ausgabe 2/2020

FDG uptake reflects breast cancer immunological features: the PD-L1 expression and degree of TILs in primary breast cancer

Tomoko Hirakata, Takaaki Fujii, Sasagu Kurozumi, Ayaka Katayama, Chikako Honda, Keiko Yanai, Shoko Tokuda, Yuko Nakazawa, Sayaka Obayashi, Reina Yajima, Kyoichi Kaira, Tetsunari Oyama, Ken Shirabe

06.04.2020 | Clinical trial | Ausgabe 2/2020 Open Access

External validation of a prognostic model based on total tumor load of sentinel lymph node for early breast cancer patients

Antonio Piñero-Madrona, Francisco Ripoll-Orts, José Ignacio Sánchez-Méndez, Asunción Chaves-Benito, Maximiliano Rodrigo Gómez-de la Bárcena, Ana Calatrava-Fons, Salomón Menjón-Beltrán, Vicente Peg-Cámara

09.04.2020 | Clinical trial | Ausgabe 2/2020

Treatment-induced symptoms, depression and age as predictors of sexual problems in premenopausal women with early breast cancer receiving adjuvant endocrine therapy

Karin Ribi, Weixiu Luo, Barbara A. Walley, Harold J. Burstein, Jacquie Chirgwin, Rafat H. Ansari, Muhammed Salim, Andre van der Westhuizen, Ehtesham Abdi, Prudence A. Francis, Stephen Chia, Vernon J. Harvey, Anita Giobbie-Hurder, Gini F. Fleming, Olivia Pagani, Angelo Di Leo, Marco Colleoni, Richard D. Gelber, Aron Goldhirsch, Alan S. Coates, Meredith M. Regan, Jürg Bernhard

10.04.2020 | Clinical trial | Ausgabe 2/2020

Phyllodes tumors of the breast: a retrospective analysis of 57 cases

Philou C. W. Noordman, Natasja M. Klioueva, Martina N. Weimann, Paul J. Borgstein, Bart C. Vrouenraets

16.04.2020 | Clinical trial | Ausgabe 2/2020 Open Access

Expression of epithelial-mesenchymal transition-related markers and phenotypes during breast cancer progression

Charlotte Levin Tykjær Jørgensen, Carina Forsare, Pär-Ola Bendahl, Anna-Karin Falck, Mårten Fernö, Kristina Lövgren, Kristina Aaltonen, Lisa Rydén

21.04.2020 | Clinical trial | Ausgabe 2/2020

Discrepancy between FDG-PET/CT and contrast-enhanced CT in the staging of patients with inflammatory breast cancer: implications for treatment planning

Heather A. Jacene, Pamela J. DiPiro, Jennifer Bellon, Jiani Hu, Su-Chun Cheng, Laura Warren, Emily Schlosnagle, Faina Nakhlis, Jennifer M. Rosenbluth, Eren Yeh, Beth Overmoyer

22.04.2020 | Clinical trial | Ausgabe 2/2020 Open Access

Prospective, randomized, single-blinded, multi-center phase II trial of two HER2 peptide vaccines, GP2 and AE37, in breast cancer patients to prevent recurrence

Tommy A. Brown II, Elizabeth A. Mittendorf, Diane F. Hale, John W. Myers III, Kaitlin M. Peace, Doreen O. Jackson, Julia M. Greene, Timothy J. Vreeland, G. Travis Clifton, Alexandros Ardavanis, Jennifer K. Litton, Nathan M. Shumway, J. Symanowski, James L. Murray, Sathibalan Ponniah, E. A. Anastasopoulou, N. F. Pistamaltzian, Constantin N. Baxevanis, Sonia A. Perez, Michael Papamichail, George E. Peoples

23.04.2020 | Clinical trial | Ausgabe 2/2020

Axillary lymph node dissection is not obligatory in breast cancer patients with biopsy-proven axillary lymph node metastasis

Tae-Kyung Yoo, Bong Joo Kang, Sung Hun Kim, Byung Joo Song, Juneyoung Ahn, Woo-Chan Park, Byung Joo Chae

06.04.2020 | Epidemiology | Ausgabe 2/2020

Association of body composition with function in women with early breast cancer

G. F. P. Aleixo, A. M. Deal, K. A. Nyrop, H. B. Muss, E. M. Damone, G. R. Williams, H. Yu, S. S. Shachar

11.04.2020 | Epidemiology | Ausgabe 2/2020

Prediction of contralateral breast cancer: external validation of risk calculators in 20 international cohorts

Daniele Giardiello, Michael Hauptmann, Ewout W. Steyerberg, Muriel A. Adank, Delal Akdeniz, Jannet C. Blom, Carl Blomqvist, Stig E. Bojesen, Manjeet K. Bolla, Mariël Brinkhuis, Jenny Chang-Claude, Kamila Czene, Peter Devilee, Alison M. Dunning, Douglas F. Easton, Diana M. Eccles, Peter A. Fasching, Jonine Figueroa, Henrik Flyger, Montserrat García-Closas, Lothar Haeberle, Christopher A. Haiman, Per Hall, Ute Hamann, John L. Hopper, Agnes Jager, Anna Jakubowska, Audrey Jung, Renske Keeman, Linetta B. Koppert, Iris Kramer, Diether Lambrechts, Loic Le Marchand, Annika Lindblom, Jan Lubiński, Mehdi Manoochehri, Luigi Mariani, Heli Nevanlinna, Hester S. A. Oldenburg, Saskia Pelders, Paul D. P. Pharoah, Mitul Shah, Sabine Siesling, Vincent T. H. B. M. Smit, Melissa C. Southey, William J. Tapper, Rob A. E. M. Tollenaar, Alexandra J. van den Broek, Carolien H. M. van Deurzen, Flora E. van Leeuwen, Chantal van Ongeval, Laura J. Van’t Veer, Qin Wang, Camilla Wendt, Pieter J. Westenend, Maartje J. Hooning, Marjanka K. Schmidt

18.04.2020 | Epidemiology | Ausgabe 2/2020

Financial toxicity and its associated patient and cancer factors among women with breast cancer: a single-center analysis of low-middle income region in China

Jingfeng Jing, Ran Feng, Xiaojun Zhang, Ming Li, Jinnan Gao

18.04.2020 | Epidemiology | Ausgabe 2/2020

Diagnostic yield of multigene panel testing in an Israeli cohort: enrichment of low-penetrance variants

Rinat Bernstein-Molho, Eitan Friedman, Inbal Kedar, Yael Laitman, Tanir M. Allweis, Einav Nili Gal-Yam, Hagit Baris Feldman, Albert Grinshpun, Naama Halpern, Shulamit Hartmajer, Luna Kadouri, Lior H. Katz, Bella Kaufman, Ido Laish, Keren Levanon, Shira Litz Philipsborn, Mark Ludman, Gal Moran, Tamar Peretz, Eyal Reinstein, Gili Reznick Levi, Tamar Safra, Shiri Shkedi, Chana Vinkler, Zohar Levy, Yael Goldberg

18.04.2020 | Epidemiology | Ausgabe 2/2020

Healthcare utilization and cost of care in elderly breast cancer patients enrolled in SWOG clinical trials

Dawn L. Hershman, Cathee Till, Jason D. Wright, Melissa Accordino, Riha Vaidya, William E. Barlow, Scott Ramsey, Joseph M. Unger

21.04.2020 | Epidemiology | Ausgabe 2/2020 Open Access

Evaluation of pathogenetic mutations in breast cancer predisposition genes in population-based studies conducted among Chinese women

Chenjie Zeng, Xingyi Guo, Wanqing Wen, Jiajun Shi, Jirong Long, Qiuyin Cai, Xiao-Ou Shu, Yongbin Xiang, Wei Zheng

23.04.2020 | Epidemiology | Ausgabe 2/2020

Ovarian removal at or after benign hysterectomy and breast cancer: a nationwide cohort study

Mathilde Gottschau, Susanne K. Kjær, Annette Settnes, Gitte Lerche Aalborg, Annet Bens, Allan Jensen, Christian Munk, Lene Mellemkjær

Aktuelle Ausgaben

Neu im Fachgebiet Onkologie

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Onkologie und bleiben Sie gut informiert – ganz bequem per eMail.

Bildnachweise